CFTR and cystic fibrosis: Infection of ORKAMBI®-rescued F508del-CFTR cells with clinical strains of P. aeruginosa that were isolated from the sputum of CF patients showed a range in loss of CFTR function, with one strain reducing CFTR activity by as much as 88% (Figure 6C; strain PA330).